Literature DB >> 3987003

Six methods for isolating high-density lipoprotein compared, with use of the reference method for quantifying cholesterol in serum.

D A Wiebe, S J Smith.   

Abstract

Using 90 serum specimens, we compared six routine procedures for high-density lipoprotein (HDL) isolation to determine the biases, if any, of each. Use of the Reference Method for cholesterol (Duncan et al., Centers for Disease Control, Atlanta, GA) and automated dispensing equipment helped ensure the accuracy of the cholesterol measurements and minimized errors from sample and reagent manipulations. Regression analysis of the results showed significant differences between most HDL isolation methods, except for those involving precipitation with heparin-MnCl2 (1.0 mol/L) or polyethylene glycol 6000, which yielded comparable results with a slope close to one and a zero intercept. The dextran sulfate (Mr 500 000)-MgCl2 method had the largest proportional and constant bias with respect to those two methods. All the methods produced comparable results in the clinically important low HDL-cholesterol range (250 to 350 mg/L), but biases were significant at high concentrations. We conclude that these increased biases in the upper ranges of HDL-cholesterol concentrations are the result of increased heterogeneity of HDL and the different mechanisms involved in forming the insoluble complexes between lipoproteins and the various precipitation reagents.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3987003

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  5 in total

1.  Effect of obesity on cardiometabolic risk factors in Asian Indians.

Authors:  D S Prasad; Zubair Kabir; A K Dash; B C Das
Journal:  J Cardiovasc Dis Res       Date:  2013-06-27

Review 2.  ACP Broad Sheet no 151: September 1997. Investigation of dyslipidaemias.

Authors:  A F Winder; W Richmond; D T Vallance
Journal:  J Clin Pathol       Date:  1997-09       Impact factor: 3.411

3.  Treatment of hypercholesterolemia with the HMG CoA reductase inhibitor, simvastatin.

Authors:  G M Berger; A D Marais; H C Seftel; S G Baker; D Mendelsohn; N H Welsh; B I Joffe
Journal:  Cardiovasc Drugs Ther       Date:  1989-04       Impact factor: 3.727

4.  Hyperlipidemia, increased lipid peroxidation and changes in antioxidant enzymes, Na(+)-K(+)-ATPase in erythrocytes of type 2 diabetic patients in andhra pradesh.

Authors:  R Giri; M M Kesavulu; B K Rao; V Ramana; C A Rao
Journal:  Indian J Clin Biochem       Date:  1999-07

5.  Subclinical atherosclerosis and silent myocardial ischaemia in patients with type 2 diabetes: a protocol of a clinico-observational study.

Authors:  D S Prasad; Zubair Kabir; K Revathi Devi; A K Dash; B C Das
Journal:  Open Heart       Date:  2014-06-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.